Impellia www.impellia.com, an injury-prevention, human performance and rehabilitation-focused technology company that includes retired Steelers quarterback Charlie Batch, has signed the license for PIVOT www.youtube.com/watch?v=oYeiSIXiweE, a software platform developed by researchers at University of Pittsburgh Medical Center (UPMC) Sports Medicine.
PIVOT www.impellia.com/pivot noninvasively quantifies the stability of the ACL in the knee and classifies the degree of injury. PIVOT can be used both as a pre-surgical diagnostic tool for orthopedic surgeons and as a tool for physical therapists to monitor patients during rehabilitation.
“We are thrilled that our PIVOT technology will be made widely available to doctors, physical therapists, and athletic trainers, said Volker Musahl, Medical Director of the UPMC Rooney Sports Complex www.upmc.com/Services/sports-medicine/facilities/rooney-complex/Pages/default.aspx and Associate Professor at the Pitt School of Medicine www.medschool.pitt.edu .
Impellia first approached the Pitt Innovation Institute www.innovation.pitt.edu two years ago to find out about Pitt technologies in the sports medicine and rehabilitation area. The Innovation Institute connects Pitt faculty and students interested in pursuing commercial opportunities related to their research discoveries with external partners interested in licensing Pitt innovations or forming new companies.
Development of PIVOT technology was supported by the Coulter Translational Research Partners II Program www.engineering.pitt.edu/coulter, a partnership between the Pitt Department of Bioengineering www.engineering.pitt.edu/bioengineering, School of Medicine, and the Innovation Institute.
Impellia partners with universities across the country to commercialize and market researcher-developed injury-prevention, human performance, and rehabilitation technologies designed to improve the fitness of everyday people and the performance of elite athletes.